Patients Harmed by 'Cost-Effectiveness' Measures

Patients Harmed by 'Cost-Effectiveness' Measures
AP Photo/M. Spencer Green, File

As someone living with epilepsy, I care about making sure drugs are affordable. As both a patient and the lead author of the Americans with Disabilities Act, I care just as much about finding solutions that engage and empower patients and people with disabilities.

Last week, CVS Caremark announced a program that does just the opposite, instead offering up a retread of paternalistic, 20th-century policy that tells patients what they're worth instead of asking them what they value.



Comment
Show comments Hide Comments


Related Articles